Determination of the renal function on the basis of the plasmaclearance of iodinated radiocontrast agend after radiography studies on critical care patients

Determination of the renal function on the basis of the plasmaclearance of iodinated radiocontrast agend after radiography studies on critical care patients - ICU-mGFR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031449

Enrollment

200

Registered

2023-03-09

Start date

2023-02-01

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N17

Interventions

Group 1: The prospective non-interventional monocentric observational study aims to determine the plasmaclearance of Iohexol after routine radiologic procedures due to reasons irrespective of this stu

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: At critical care ward, Iohexol is given for a procedure irrespective of the study.

Exclusion criteria

Exclusion criteria: Any of the following while samples are being obtained: ECMO therapy, renal replacement therapy or large volume shifts (f.i. massive transfusion or large blood loss). Pregnancy.

Design outcomes

Primary

Measure	Time frame
Feasibility of measurement of renal function (mGFR) based on Iohexolclearance	—

Secondary

Measure	Time frame
Comparison of mGFR (based on Iohexol based) with eGFR (Creatinin/Cystacin-C based)	—

Countries

Germany

Contacts

Public ContactAlexander Dejaco

Universitätsklinikum Regensburg

alexander.dejaco@ukr.de0944 941 7801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026